Join
Live feed
·
INSIDERFilingvia Quantisnow
Abeona Therapeutics Inc. logo

Director Alvino Mark sold $12,760 worth of shares (2,000 units at $6.38), decreasing direct ownership by 2% to 90,435 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABEO (Abeona Therapeutics Inc.) and more on Quantisnow.